The identification of proliferation and tumour-induced proteins in human endothelial cells: A possible target for tumour therapy
β Scribed by Mark S. F. Clarke; Dr. David C. West
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 951 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0173-0835
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background We describe an __in vitro__ tumour model for targeted radiotherapy and gene therapy that incorporates cell population heterogeneity. ## Materials and methods Transfectant mosaic spheroids (TMS) and transfected mosaic monolayers (TMM) are composed of two cell populations
In marked contrast to ligands which activate B cells via their physiological receptors for antigen, transforming Epstein-Barr virus (EBV) was found to be mitogenic for human B lymphocytes without increasing inositol phospholipid hydrolysis. B-cell stimulation by EBV showed similar characteristics to
The purpose of this study was to determine whether cultured colonic adenoma and carcinoma cells undergo apoptosis (programmed cell death) in vitro and whether specific growth and dietary factors, thought to be involved in the control of growth and differentiation of human colonic cells, could induce
## Abstract Clinical and experimental data suggest that ErbBβ4, a member of the epidermal growth factor receptor family, may have a role in cancer progression and response to treatment. We found recently, using a retrospective clinical analysis, that expression of ErbBβ4 receptor is correlated with
During vascular development, endothelial cells are exposed to a variety of rapidly changing factors, including fluctuating oxygen levels. We have previously shown that ankyrin repeat and suppressor of cytokine signalling box protein 4 (ASB4) is the most highly differentially expressed gene in the va